The investigators delineated a specific WNT5A signaling axis, i.e., FZD3/Gαs/cAMP/PKA, to be responsible for the DARPP-32 and CREB-dependent anti-migratory effects in breast cancer cells [37]. Here, WNT5A is linked to breast carcinoma.